There is a plethora of evidence suggestive of the inhibitory role conferred by DIRAS3 on tumor growth of various cancers [24,31–33], however, but its potential role and mechanism in NSCLC remain to be unknown. This evidence concerns the gene DIRAS3 and neoplasm.